Aliberti Stefano Ottobre 2018 - unimi.it · Pneumologia (SIP/IRS) 2014-2018 Rappresentante dei...

AlibertiStefano Ottobre2018

STEFANOALIBERTICURRICULUMVITAE

INFORMAZIONIPERSONALI

COGNOME ALIBERTI

NOME STEFANO

DATADINASCITA 29NOVEMBRE1978A1.TITOLIACCADEMICI

1.4.2016-adoggi ProfessoreAssociatoinMalattiedell’ApparatoRespiratorioDipartimentodiFisiopatologiaMedico-ChirurgicaedeitrapiantiUniversitàdegliStudidiMilano,Milano

1.8.2017-1.8.2023 Abilitatoper le funzionidiprofessoredi I fascia(ordinario)BandoD.D.1532/2016; Settore concorsuale 06/D1 Malattie dell’ApparatoCardiovascolareeMalattiedell’Apparatorespiratorio(art.16,comma1,Legge240/10)

1.12.2010-31.3.2016 RicercatoreUniversitarioScuoladiMedicinaeChirurgiaUniversitàdegliStudidiMilano-Bicocca,Milano

1.9.2008-31.7.2009 Vincitorediconcorsopubblico,per titoliedesami,per ilconferimentodi un assegno di ricerca presso Dipartimento Toraco-Polmonare eCardio-Circolatorio (DR n. 254915 del 21/5/08) dell’Università degliStudi di Milano, Milano, dal titolo “Bronchiectasie nel paziente conBPCO:prevalenzaecolonizzazionebatterica”

2007 SpecialistainMalattiedell’ApparatoRespiratorioUniversitàdegliStudidiMilano

2003 MedicoChirurgoUniversitàdeglistudidiMilano

A2.FORMAZIONE

1.10.2003-1.11.2007

SpecializzazioneinMalattiedell’App.Respiratorio(70/70eLode)UniversitàdegliStudidiMilano,Milano

31.10.2006-30.10.2007

ClinicalResearchFellowshipDivisionofInfectiousDiseases,InternalMedicineDepartmentUniversityofLouisville,Louisville,KY,USA


1.4.2008-adoggi InvestigatoredalMaggio2015Co-Direttoredel“Community-acquiredpneumoniaOrganization-CAPO”InternationalStudyGroup(www.caposite.com)

30.10.2007-adoggi Investigatordel“Community-acquiredpneumoniaInflammatoryStudyGroup(CAPISG)”

1.1.2004 VincitorediBorsadiricercacorrentedell’OspedaleMaggiorePoliclinicodiMilanodaltitolo“TerapiaconsalbutamolonebulizzatovssalbutamoloaerosolnelpazienteconBPCOriacutizzata(AECB)chenecessitadiventilazionenoninvasiva(NIV)”

4.8.2004-4.9.2004

ClinicalFellowshipAcuteRespiratoryMedicineUnit,St.James’sUniversityHospital,NHStrust,Leeds,WestYorkshire,UK

2.10.2002-31.10.2002

InternshipTraumaSurgery,Unfallchirurgie,KlinikundPoliklinikfurChirurgiederUniversitatBonn,UniversityHospital,Bonn,Germany

Agosto2000

Internship,Medicine,EmergencyRoomandSurgeryChaimShebaMedicalCenterSacklerSchoolofMedicineTel-AvivUniversity,Tel-Hashomer,Tel-Aviv,Israel

1997-2003

LaureainMedicinaeChirurgia(110/110eLode)UniversitàdegliStudidiMilano,Milano

A3.CERTIFICAZIONIEDIPLOMI

Settembre2010 EuropeanexaminationinAdultRespiratoryMedicine2010(HERMESexamination)Diploma,EuropeanRespiratorySocietyInstituteofEducation,UniversityofBerne,CH

Dicembre2008 ALS:AdvanceLifeSupportCertificateEuropeanResuscitationCouncil,ItalianResuscitationCounciln°:09870

Maggio2008 SeminarinMedicalwritingforspecialistsinrespiratorydiseaseInstituteforAppliedLanguageStudiesUniversityofEdinburgh,Scotland,UK

Dicembre2006 CITIBiomedicalcertification,HumanSubjectsResearchIntegrityProgram,UniversityofLouisville,Louisville,KY,USA

29.9.2005 BLS-D:BasicLifeSupport–DefibrillationCertificate,Milan


27.1.2004 Iscrizioneall’AlbodeiMedicidell’OrdineProvincialedeiMediciChirurghiedegliOdontoiatridiMilano(#39041),dell’OrdinedeiMediciChirurghieOdontoiatridellaProvinciadiMonzaeBrianza(#02938)dal10.6.2008al16.1.2017,eall’AlbodeiMedicidell’OrdineProvincialedeiMediciChirurghiedegliOdontoiatridiMilano(#44789)Dal17.1.2017

23.8.2004 “Fullregistrationasmedicalpractitioner”,GMCreferencenumber6103409GeneralMedicalCouncil,UK

B.ATTIVITA’DIRICERCAB1.GRANTDAENTIPUBBLICI2014Vincitoredifinanziamentoregionale(RegioneLombardia)conddgSaluten.6848del

16.7.2014 (ricerca indipendente2012)di 243.000,00europer il progettodal Titolo“Ruolo della colonizzazione ed infezione virale sulle riacutizzazioni edospedalizzazioniinpazientiaffettidabronchiettasie(LostudioVIBRO)”

2018 Vincitore di finanziamento per “Bando Direzione Scientifica utilizzo Piattaforme

Interne” del Policlinico di Milano di 64.892,00 euro per il progetto dal titolo:“Evaluation of transcriptome patterns to better understand host-pathogeninteractionincysticfibrosisandbronchiectasispatientswithchronicinfectionduetoPseudomonasaeruginosaandnon-tuberculousmycobacteria”

B2.AWARDERICONOSCIMENTI2007 Vincitore del “2007 Young researcher award: respiratory infection etiologic

diagnosis”dellaEuropeanRespiratorySociety2006 Invitatoal“4thEuropeanRespiratoryNetworkofExcellence”Brussels,Belgio2004 VincitorediBorsadiricercacorrentedell’OspedaleMaggiorePoliclinicodiMilanodal

titolo“Terapiaconsalbutamolonebulizzatovs.salbutamoloaerosolnelpazienteconBPCOriacutizzata(AECB)chenecessitadiventilazionenoninvasiva(NIV)”

B3.VISITINGPROFESSORSHIPLuglio2018 VisitingProfessorship,UniversitàdegliStudidiSassari,ItaliaB4.MEMBERSHIPeIMPEGNIINSOCIETA’SCIENTIFICHENAZIONALI2014-adoggi MembrodellaSocietàItalianadiPneumologia(SIP/IRS)

• Autore delle raccomandazioni SIP e SITI sull’uso della vaccinazioneantipneumococcica


• Direttore dell’Osservatorio Italiano di pazienti adulti affetti da bronchiettasienon dovute a fibrosi cistica (IRIDE) della Società Italiana di Pneumologia(SIP/IRS)

• Direttore del’ Audit Nazionale SIP sulla gestione dei pazienti adulti affetti dabronchiettasienondovuteafibrosicistica

• Docente e/o Coordinatore scientifico della SIP HERMES National SummerSchool(anni:2011,2012,2013,2014,2016)

• Relatoree/oCoordinatorescientificodipiùdi20eventiscientifici/educazionaliorganizzatidaSIPnegliultimi5anni

2018-adoggi Responsabile del Gruppo di Studio Infezioni Respiratorie della Società Italiana di

Pneumologia(SIP/IRS)2014-2018RappresentantedeiYoungmembersdellaSocietàItalianadiPneumologia(SIP/IRS)

2018- ad oggi Scientific Expert Reviewer del 2017 AIFA Call per Protocolli sottomessi alla RicercaClinicaIndipendente

B5.MEMBERSHIPeIMPEGNIINSOCIETA’SCIENTIFICHEINTERNAZIONALI2017–adoggi CurriculumDevelopmentDirector,EuropeanRespiratorySociety https://www.ersnet.org/the-society/who-we-are/leadership/education-council Membrodell’EducationalCouncildellaEuropeanRespiratorySociety2017–adoggi MembrodelClinicalResearchCollaborationsWorkingGroupdellaEuropean

RespiratorySociety2015–2017 MembrodellaResearchAgencydellaEuropeanRespiratorySociety2014–2017 Membrodell’ExecutiveCommitteedellaEuropeanRespiratorySociety2014–2017 MembrodelScienceCouncildellaEuropeanRespiratorySociety2011–2014 Membrodell’EducacionalCouncildellaEuropeanRespiratorySociety2012–2017 MembrodelLong-RangePlanningCommitteedellaRespiratoryInfection

AssemblydellaEuropeanRespiratorySociety2014-2017 Head della Respiratory Infection Assembly (Assembly 10) della EuropeanRespiratorySociety2012–2014 SegretariodellaRespiratory InfectionAssembly(Assembly10)dellaEuropean

RespiratorySociety(ERS) 2011–2012 SegretariodelRespiratoryInfectionGroup(Group10.1,Assembly10, RespiratoryInfectionAssembly)dellaEuropeanRespiratorySociety2014-2017 MembrodellaTaskForcedellelineeguidaERSsu“Managementofadultnon-

CFbronchiectasis”


2018–adoggi MembrodellaTaskForcedellelineeguidaERSsu“SevereCommunity-Acquired

Pneumonia”2014-adoggi FondatoreeDirettoredelRegistroEuropeodelleBronchiettasie (EuropeanBronchiectasisRegistry-EMBARC;www.bronchiectasis.eu)

• MembrodelloSteeringCommitteediEMBARC• MembrodelPublicationCommitteediEMBARC

2014-adoggi MembrodelloStandardofCareWorkingGroupdellaEuropeanCysticFibrosis

Societyecoordinatordelprogetto“QualityStandardsforAdultCFCare”2014-adoggi Membrodell’InternationalAdvisoryBoarddelRegistroTedescodelle Bronchiettasie(GermanBronchiectasisRegistry-PROGNOSIS)2015-adoggi Membrodell’ExecutiveCommitteedell’EuropeanNetworkforICU- relatedrespiratoryinfections(ENIRRI)2015-2017 DirettoredelCommunity-AcquiredPneumoniaOrganization (www.caposite.com)2014-2018 Membro del Management Council dell’European Board for Accreditation in

Pneumology(www.ebap.org)2014-2017 MembrodelAdhocWorkingGrouponTuberculosisAdvocacydell’European

RespiratorySociety2006–adoggi Membrodell’EuropeanRespiratorySociety(n.127147)2013 -adoggi MembrodellaEuropeanSocietyofClinicalMicrobiologyandInfectious

Diseases2014-adoggi MembrodellaAmericanThoracicSociety(n.232289)B6.IMPEGNIEDITORIALI2017-adoggi AssociateEditor,Respirology2015-adoggi AssociateEditor,EuropeanRespiratoryJournalOpenResearch2016-adoggi AssociateEditor,MultidisciplinaryRespiratoryMedicine2016-2018 AssociateEditor,BMCPulmonaryMedicine2014-adoggi EditorialBoard,InternationalJournalofMycobacteriology2016-adoggi EditorialBoard,UniversityofLouisvilleJournalofRespiratoryInfections2013 AssociateEditor,EuropeanRespiratoryMonograph


2010-2016 SectionEditor,“Pulmonology”,EuropeanJournalofInternalMedicine2012-2014 EditorialBoard,“Breathe”Journal,EuropeanRespiratorySocietyReviewerperiseguentigiornaliinternazionali:TheCochraneCollaboration;LancetInfectiousDiseases;AmericanJournalofRespiratoryandCriticalCareMedicine; European Respiratory Journal; Thorax; Clinical Infectious Diseases, Plos One; Chest; IntensiveCareMedicine;EuropeanRespiratoryHandbook;EuropeanRespiratoryMonograph;EuropeanRespiratoryReview; The Clinical Respiratory Journal; Respiratory Research; COPD: Journal of chronic obstructivepulmonary disease; BMC Infectious Diseases; Respirology; Respiratory Medicine; European Journal ofInternal Medicine; Pulmonary Pharmacology and Therapeutics; Internal and Emergency Medicine;MultidisciplinaryRespiratoryMedicine;MonaldiArchivesforChestDiseases–PulmonarySeries.B7.PROGETTIDIRICERCAINCORSO

• Direttore dell’osservatorio italiano delle micobatteriosi polmonari non-tubercolari (IRENE,www.registroirene.it;clinicaltrial.govNCT03339063)

• Direttoredell’osservatorioitalianodellebronchiettasie(IRIDE;http://www.sipirs.it/cms/iride/)• DirettoredelRegistroEuropeodelleBronchiettasie(EMBARC,www.bronchiectasis.eu)• MembroeFondatoredell’EuropeanRegistryofNTM-PD(RegistroEuropeodellamalattiapolmonare

daNTM)• Responsabile del Programma di Ricerca Clinica e Translazionale sulle infezioni croniche,

bronchiettasie,PCDeNTMdelPoliclinicodiMilano• Coordinatore della Ricerca Clinica e Translazionale, sia spontanea che sponsorizzata dell’UOC

Broncopneumologia del Policlinico di Milano (ad oggi più di 20 protocolli di ricerca attiviosservazionaleeinterventisticiinambitodiBronchiettasie,InfezioniRespiratorieAcuteeCroniche,BPCO,AsmaGrave,FibrosiCistica,eTrapiantodipolmone)

B8.PUBBLICAZIONI

• ORCID:http://orcid.org/0000-0002-0090-4531• H-index:34(GoogleScholar;Ottobre2018);30(Scopus;Ottobre2018)

B8a.ArticoliPeerreviewed

1. PolliniS,DiPilatoV,LandiniG,DiMaggioT,CannatelliA,SottotettiS,CarianiL,AlibertiS,BlasiF,SergioF,RossoliniGM,PallecchiL. InvitroactivityofN-acetylcysteineagainstStenotrophomonasmaltophilia andBurkholderia cepacia complex grown inplanktonic phase andbiofilm. PLoSOne.2018Oct1;13(10):e0203941.

2. AlibertiS,CodecasaLR,GoriA,SotgiuG,SpottiM,DiBiagioA,CalcagnoA,NardiniS,AssaelBM,Tortoli E, BesozziG, FerrareseM,Matteelli A,Girardi E,De Lorenzo S, SeiaM,GramegnaA,DelPratoB,TerranovaL,OrianoM,SverzellatiN,MirsaeidiM,ChalmersJD,HaworthCS,LoebingerMR,AksamitT,WinthropK,RingshausenFC,PrevidiG,Blasi F; IRENENetwork.The Italian registryofpulmonary non-tuberculous mycobacteria - IRENE: the study protocol. Multidiscip Respir Med.2018Aug9;13(Suppl1):33.


3. GramegnaA,Aliberti S, SeiaM,Porcaro L,BianchiV,CastellaniC,Melotti P, SorioC,ConsalvoE,FranceschiE,AmatiF,ContariniM,GaffuriM,RoncoroniL,VigoneB,BellofioreA,DelMonacoC,OrianoM,TerranovaL,PatriaMF,MarchisioP,AssaelBM,BlasiF.Whenandhowrulingoutcysticfibrosisinadultpatientswithbronchiectasis.MultidiscipRespirMed.2018Aug9;13(Suppl1):29.

4. Aliberti S, Chalmers JD. Get together to increase awareness in bronchiectasis: a report of the2ndWorldBronchiectasisConference.MultidiscipRespirMed.2018Aug9;13(Suppl1):28.

5. ContariniM, Shoemark A, Rademacher J, Finch S, Gramegna A, GaffuriM, Roncoroni L, SeiaM,Ringshausen FC, Welte T, Blasi F,Aliberti S, Chalmers JD. Why, when and how to investigateprimaryciliarydyskinesia inadultpatientswithbronchiectasis.MultidiscipRespirMed.2018Aug9;13(Suppl1):26.

6. PacileoG,TozziVD,SotgiuG,AlibertiS,MorandoV,BlasiF.Administrativedatabasesandclinicalgovernance:ThecaseofCOPD.IntJHealthPlannManage.2018Aug16.

7. GramegnaA,Dellafiore S, ContariniM,Blasi F,Aliberti S, TosattoR,ManteroM.Knowledge andattitudesoninfluenzavaccinationamongItalianphysiciansspecializedinrespiratoryinfections:anItalian Respiratory Society (SIP/IRS) web-based survey. J Prev Med Hyg. 2018 Jun 1;59(2):E128-E131.

8. Polverino E, Dimakou K, Hurst J, Martinez-Garcia MA, Miravitlles M, Paggiaro P, ShteinbergM,AlibertiS,ChalmersJD.Theoverlapbetweenbronchiectasisandchronicairwaydiseases:stateoftheartandfuturedirections.EurRespirJ.2018Sep15;52(3).

9. RestrepoMI, Babu BL, Reyes LF, Chalmers JD, Soni NJ, Sibila O, Faverio P, Cilloniz C, Rodriguez-Cintron W,Aliberti S; GLIMP. Burden and risk factors forPseudomonas aeruginosacommunity-acquiredpneumonia:amultinationalpointprevalencestudyofhospitalisedpatients.EurRespirJ.2018Aug9;52(2).

10. Arnold FW, Lopardo G, Wiemken TL, Kelley R, Peyrani P, Mattingly WA, Feldman C, Gnoni M,MauriciR,RamirezJA;Community-AcquiredPneumoniaOrganization(CAPO).Macrolidetherapyisassociatedwithlowermortalityincommunity-acquiredbacteraemicpneumonia.RespirMed.2018Jul;140:115-121.

11. Pollini S, Boncompagni S, DiMaggio T, Di Pilato V, Spanu T, Fiori B, Blasi F,Aliberti S, Sergio F,RossoliniGM,PallecchiL.InvitrosynergismofcolistinincombinationwithN-acetylcysteineagainstAcinetobacterbaumanniigrowninplanktonicphaseandinbiofilms.JAntimicrobChemother.2018Sep1;73(9):2388-2395.

12. MiglioriGB,SotgiuG,Rosales-KlintzS,CentisR,D'AmbrosioL,AbubakarI,BothamleyG,CamineroJA,CirilloDM,DaraM,deVriesG,AlibertiS,Dinh-XuanAT,DuarteR,MidullaF,SolovicI,SuboticDR, AmicosanteM, Correia AM, Cirule A, Gualano G, Kunst H, Palmieri F, Riekstina V, Tiberi S,VerduinR,vanderWerfMJ.ERS/ECDCStatement:EuropeanUnionstandardsfortuberculosiscare,2017update.EurRespirJ.2018May17;51(5).

13. SotgiuG,AreBM,PesapaneL,PalmieriA,MuresuN,CossuA,DettoriM,AzaraA,MuraII,CocuzzaC,Aliberti S,PianaA.Nosocomial transmissionof carbapenem-resistantKlebsiellapneumoniae inanItalianuniversityhospital:amolecularepidemiologicalstudy.JHospInfect.2018Aug;99(4):413-418

14. Gutbier B, Neuhauß AK, Reppe K, Ehrler C, Santel A, Kaufmann J, Scholz M, Weissmann N,Morawietz L, Mitchell TJ,Aliberti S, Hippenstiel S, Suttorp N, Witzenrath M; CAPNETZ andPROGRESSStudyGroups‡PrognosticandPathogenicRoleofAngiopoietin-1and-2inPneumonia.AmJRespirCritCareMed.2018Jul15;198(2):220-231.

15. PaoliniV,FaverioP,Aliberti S,MessinesiG,FotiG,SibilaO,MonzaniA,DeGiacomiF,StainerA,PesciA.Positiveendexpiratorypressureinacutehypoxemicrespiratoryfailureduetocommunityacquired pneumonia: do we need a personalized approach? PeerJ 2018; 6:e4211; DOI10.7717/peerj.4211

16. Araújo D, Shteinberg M,Aliberti S, Goeminne PC, Hill AT, Fardon TC, Obradovic D, Stone G,Trautmann M, Davis A, Dimakou K, Polverino E, De Soyza A, McDonnell MJ, Chalmers JD. Theindependent contributionofPseudomonasaeruginosainfection to long-termclinical outcomes inbronchiectasis.EurRespirJ.2018Jan31;51(2).pii:1701953.


17. ChalmersJD,AlibertiS,FilonenkoA,ShteinbergM,GoeminnePC,HillAT,FardonTC,ObradovicD,GerlingerC,SotgiuG,OperschallE,RutherfordRM,DimakouK,PolverinoE,DeSoyzaA,McDonnellMJ.Characterisationof the"FrequentExacerbatorPhenotype" inBronchiectasis.AmJRespirCritCareMed.2018Jan22.

18. ChalmersJD,RingshausenFC,HarrisB,ElbornJS,PosthumusA,HaworthCS,PilkingtonN,PolverinoE,RuddyT,AlibertiS,GoeminnePC,WinstanleyC,DeSoyzaA.Cross-infectionriskinpatientswithbronchiectasis: a position statement from the European Bronchiectasis Network (EMBARC),EMBARC/ELFpatientadvisorygroupandEuropeanReferenceNetwork (ERN-Lung)BronchiectasisNetwork.EurRespirJ.2018Jan11;51(1).pii:1701937.

19. GramegnaA,AmatiF,TerranovaL,SotgiuG,TarsiaP,MigliettaD,CalderazzoMA,AlibertiS,BlasiF.Neutrophilelastaseinbronchiectasis.RespirRes.2017Dec19;18(1):211.[correspondingauthor]

20. BediP,ChalmersJD,GoeminnePC,MaiC,SaravanamuthuP,VeluPP,CartlidgeMK,LoebingerMR,Jacob J, Kamal F, Schembri N,Aliberti S, Hill U, HarrisonM, Johnson C, Screaton N, Haworth C,PolverinoE,RosalesE,TorresA,BenegasMN,RossiAG,PatelD,HillAT.TheBRICS(BronchiectasisRadiologically Indexed CT Score): A Multicenter Study Score for Use in Idiopathic andPostinfectiveBronchiectasis.Chest.2017Dec13.pii:S0012-3692(17)33213-0

21. Araújo D, Shteinberg M,Aliberti S, Goeminne PC, Hill AT, Fardon T, Obradovic D, Dimakou K,PolverinoE,DeSoyzaA,McDonnellMJ,ChalmersJD.Standardisedclassificationoftheaetiologyofbronchiectasisusinganobjectivealgorithm.EurRespirJ.2017Dec14;50(6).

22. DePascaleG,RanzaniOT,NseirS,ChastreJ,WelteT,AntonelliM,NavalesiP,GarofaloE,BruniA,CoelhoLM,SkoczynskiS,LonghiniF,TacconeFS,GrimaldiD,SalzerHJF,LangeC,FroesF,ArtigasA,DíazE,VallésJ,RodríguezA,PanigadaM,ComelliniV,FasanoL,SoavePM,SpinazzolaG,LuytCE,Alvarez-Lerma F, Marin J, Masclans JR, Chiumello D, Pezzi A, Schultz M, Mohamed H, Van DerEerdenM,HoekRAS,GommersDAMPJ,PasqualeMD,CivljakR,KutlešaM,BassettiM,DimopoulosG,NavaS,RiosF,ZampieriFG,PovoaP,BosLD,AlibertiS,TorresA,Martín-LoechesI.Intensivecareunitpatientswithlowerrespiratorytractnosocomialinfections:theENIRRIsproject.ERJOpenRes.2017Nov17;3(4).

23. Biondi G, Sotgiu G, Dore S, Molicotti P, Ruggeri M,Aliberti S, Satta R. Beyond pulmonarynontuberculousmycobacteria disease: do extra-pulmonary forms represent an emerging clinicalandpublichealththreat?ERJOpenRes.2017Sep19;3(3)

24. Martin-LoechesI,ZampieriF,PovoaP,RanzaniO,BosLD,AlibertiS,TorresA.RespiratoryresearchnetworksinEuropeandbeyond:aims,achievementsandaspirationsforthe21stcentury.Breathe(Sheff).2017Sep;13(3):209-215.

25. Chalmers JD, CrichtonM, Goeminne PC, LoebingerMR, Haworth C, AlmagroM, VendrellM, DeSoyza A, Dhar R, Morgan L, Blasi F,Aliberti S, Boyd J, Polverino E. The European MulticentreBronchiectasis Audit and Research Collaboration (EMBARC): experiences from a successful ERSClinicalResearchCollaboration.Breathe(Sheff).2017Sep;13(3):180-192.

26. SinganayagamA,AlibertiS,CillónizC,TorresA,BlasiF,Chalmers JD.Evaluationofseverityscore-guided approaches tomacrolide use in community-acquired pneumonia. Eur Respir J. 2017 Sep10;50(3)

27. PolverinoE,GoeminnePC,McDonnellMJ,AlibertiS,MarshallSE,LoebingerMR,MurrisM,CantónR,TorresA,DimakouK,DeSoyzaA,HillAT,HaworthCS,VendrellM,RingshausenFC,SuboticD,WilsonR,VilaróJ,StallbergB,WelteT,RohdeG,BlasiF,ElbornS,AlmagroM,TimothyA,RuddyT,Tonia T, Rigau D, Chalmers JD. European Respiratory Society guidelines for themanagement ofadultbronchiectasis.EurRespirJ.2017Sep9;50(3).

28. Mantero M,Aliberti S, Azzari C, Moriondo M, Nieddu F, Blasi F, Di Pasquale M. Role ofStreptococcus pneumoniae infection in chronic obstructive pulmonary disease patients in Italy.TherAdvRespirDis.2017Oct;11(10):403-407.

29. Al-Jahdali H, Alshimemeri A, Mobeireek A, Albanna AS, Al Shirawi NN,Wali S, Khaled Alkattan,AbdulrahmanAAlrajhi,KhalidMobaireek,HassanSAlorainy,MohamedSAl-Hajjaj,AnneBChang,StefanoAliberti.TheSaudiThoracicSocietyguidelinesfordiagnosisandmanagementofnoncysticbrosisbronchiectasis.AnnThoracMed2017;12:135-61.


30. Di Pasquale M, Aliberti S, Azzari C, Mantero M. Serotypes and antibiotic susceptibility of S.pneumoniaeisolatedinCAPinItaly.SAGEOpenMedicine2017;5:11.

31. Carpagnano GE, Santacroce R, Palmiotti GA, Leccese A, Giuffreda E, Margaglione M, FoschinoBarbaroMP,AlibertiS,LacedoniaD.ANewSERPINA-1MissenseMutationAssociatedwithAlpha-1AntitrypsinDeficiencyandBronchiectasis.Lung.2017Jul1.doi:10.1007/s00408-017-0033-2

32. RodríguezA,FerriC,Martin-LoechesI,DíazE,MasclansJR,GordoF,Sole-ViolánJ,BodíM,Avilés-Jurado FX, Trefler S, Magret M, Moreno G, Reyes LF, Marin-Corral J, Yebenes JC, Esteban A,AnzuetoA,Aliberti S,RestrepoMI.RiskFactors forNoninvasiveVentilationFailure inCritically IllSubjectsWithConfirmedInfluenzaInfection.RespirCare.2017Jul11.

33. Mangat M, Amalakuhan B, Habib S, Reyes LF, Hinojosa CA, Rodriguez AH, Soni NJ, Anzueto A,Levine SM, Peters JI, Aliberti S, Sibila O, Rello J, WitzenrathM,Waterer GW,Martin-Loeches I,Blanquer J, Sanz F,Marcos PJ, Solé-Violán J, Chalmers JD, Feldman C,Wunderink RG, Cruz CSD,Orihuela CJ, Restrepo MI. High endocan levels are associated with the need for mechanicalventilationamongpatientswithseveresepsis.EurRespirJ.2017Jul5;50(1).

34. AlibertiS,RamirezJ,GiulianiF,WiemkenT,SotgiuG,TedeschiS,CarugatiM,ValentiV,MarchioniM,CameraM,PiroR,Del FornoM,MilaniG, FaverioP, Richeldi L,DeottoM,VillaniM,VozaA,TobaldiniE,BernardiM,BelloneA,BassettiM,BlasiF.Individualizingdurationofantibiotictherapyincommunity-acquiredpneumonia.PulmPharmacolTher.2017Jun27.pii:S1094-5539(17)30064-0.[correspondingauthor]

35. ReyesLF,RestrepoMI,HinojosaCA,SoniNJ,AnzuetoA,BabuBL,Gonzalez-JuarbeN,RodriguezAH,Jimenez A, Chalmers JD,Aliberti S, Sibila O, Winter VT, Coalson JJ, Giavedoni LD, Dela Cruz CS,WatererGW,WitzenrathM, SuttorpN, Dube PH,Orihuela CJ. Severe Pneumococcal PneumoniaCauses Acute Cardiac Toxicity and Subsequent Cardiac Remodeling. Am J Respir Crit CareMed.2017Jun14.doi:10.1164/rccm.201701-0104OC

36. HillAT,HaworthCS,AlibertiS,BarkerA,BlasiF,BoersmaW,ChalmersJD,DeSoyzaA,DimakouK,Elborn JS, FeldmanC, FlumeP,GoeminnePC, LoebingerMR,MenendezR,Morgan L,MurrisM,PolverinoE,QuittnerA,RingshausenFC,TinoG,TorresA,VendrellM,WelteT,WilsonR,WongC,O'DonnellA,AksamitT;EMBARC/BRRdefinitionsworkinggroup.Pulmonaryexacerbationinadultswithbronchiectasis:aconsensusdefinitionforclinicalresearch.EurRespirJ.2017Jun8;49(6).pii:1700051.

37. Solovic I,Abubakar I,SotgiuG,DaraM,GolettiD,DuarteR,AlibertiS,deBenedictisFM,WardB,TeixeiraV,GratziouC,MiglioriGB.Standardoperatingproceduresfortuberculosiscare.EurRespirJ.2017Jun1;49(6).pii:1700515.

38. Cazzola M, Rogliani P,Aliberti S, Blasi F, Matera MG. An update on the pharmacotherapeuticmanagementoflowerrespiratorytractinfections.ExpertOpinPharmacother.2017Jul;18(10):973-988

39. Nosotti M, Dell'Amore A, Diso D, Oggionni T,Aliberti S; Study Group for Thoracic OrgansTransplantation. Selection of Candidates for Lung Transplantation: The First Italian ConsensusStatement.TransplantProc.2017May;49(4):702-706

40. WiemkenTL,KelleyRR,Fernandez-BotranR,MattinglyWA,ArnoldFW,FurmanekSP,RestrepoMI,Chalmers JD, Peyrani P, Cavallazzi R, Bordon J, Aliberti S, Ramirez JA. Using cluster analysis ofcytokines to identify patterns of inflammation in hospitalized patients with community-acquiredpneumonia:apilotstudy.UnivLouisvilleJRespirInfect.2017;1(1):3-11.

41. BodiniR, SantusP,DiMarcoF,Aliberti S,CentanniS,Blasi F,RizziA,RecchiaG.EpidemiologyofclinicaltrialsofmedicinesinrespiratorydiseasesinEuropeandItaly.RespirMed.2017Apr;125:8-11

42. Amati F, Franceschi E, Gramegna A, Chalmers JD, Aliberti S. Investigating the Etiology ofBronchiectasis: You Do Not Find What You Do Not Look For. Respiration. 2017;93(3):228-229.[correspondingauthor]

43. AlibertiS,DharR,AksamitTR,MorganL,ChalmersJD.AdditionalimportantresearchprioritiesforbronchiectasisinChina.EurRespirJ.2017Jan18;49(1).[correspondingauthor]


44. De Soyza A, McDonnell MJ, Goeminne PC, Aliberti S, Lonni S, Davison J, Dupont LJ, Fardon TC,Rutherford RM, Hill AT, Chalmers JD.Bronchiectasis Rheumatoid overlap syndrome (BROS) is anindependent risk factor formortality inpatientswithbronchiectasis:Amulticentre cohort study.Chest.2017Jan13.pii:S0012-3692(17)30009-0.

45. AlibertiS,BlasiF.Bronchiectasisin2016:advancesinourunderstanding.LancetRespirMed.2016Dec;4(12):940-941.[correspondingauthor]

46. WiemkenTL,KelleyRR,Fernandez-BotranR,MattinglyWA,ArnoldFW,FurmanekSP,RestrepoMI,Chalmers JD, Peyrani P, Cavallazzi R, Bordon J, Aliberti S, Ramirez JA. Using cluster analysis ofcytokines to identify patterns of inflammation in hospitalized patients with community-acquiredpneumonia:apilotstudy.ULJRI2017;1(1):3-11.

47. McDonnellMJ,AlibertiS,GoeminnePC,RestrepoMI,FinchS,PesciA,DupontLJ,FardonTC,WilsonR,LoebingerMR,SkrbicD,ObradovicD,DeSoyzaA,WardC,LaffeyJG,RutherfordRM,ChalmersJD. Comorbidities and the risk of mortality in patients with bronchiectasis: an internationalmulticentrecohortstudy.LancetRespirMed.2016Dec;4(12):969-979.

48. FaverioP,StainerA,BonaitiG,ZucchettiSC,SimonettaE,LapadulaG,MarruchellaA,GoriA,BlasiF,Codecasa L, Pesci A, Chalmers JD, Loebinger MR, Aliberti S. Characterizing Non-TuberculousMycobacteriaInfectioninBronchiectasis.IntJMolSci.2016Nov16;17(11).[correspondingauthor]

49. Sotgiu G, Beer N, Aliberti S,Migliori GB, van derWerfMJ. Fighting tuberculosis in the EU/EEA:towards the new European Union standards on tuberculosis care. Eur Respir J. 2016Nov;48(5):1278-1281.

50. DeSoyzaA,AlibertiS.BronchiectasisandAspergillus:Howaretheylinked?MedMycol.2016Oct28.pii:myw109.[Epubaheadofprint]

51. PolverinoE,BothamleyGH,GolettiD,Heyckendorf J, SotgiuG,Aliberti S.Thebestof respiratoryinfectionsfromthe2015EuropeanRespiratorySocietyInternationalCongress.ERJOpenRes.2016Jul11;2(3).pii:00049-2016.

52. Amalakuhan B, Habib SA, Mangat M, Reyes LF, Rodriguez AH, Hinojosa CA, Soni NJ, Gilley RP,BustamanteCA,AnzuetoA,LevineSM,PetersJI,AlibertiS,SibilaO,ChalmersJD,TorresA,WatererGW,Martin-Loeches I, Bordon J, Blanquer J, Sanz F,Marcos PJ, Rello J, Ramirez J, Solé-Violán J,LunaCM,FeldmanC,WitzenrathM,WunderinkRG,StolzD,WiemkenTL,ShindoY,DelaCruzCS,Orihuela CJ, RestrepoMI. Endothelial adhesionmolecules andmultiple organ failure in patientswithseveresepsis.Cytokine.2016Dec;88:267-273.

53. BellelliG,ChalmersJD,SotgiuG,DoreS,McDonnellMJ,GoeminnePC,DimakouK,SkrbicD,LombiA, Pane F, Obradovic D, Fardon TC, Rutherford RM, Pesci A, Aliberti S. Characterization ofbronchiectasisintheelderly.RespirMed.2016Oct;119:13-19.[correspondingauthor]

54. Aliberti S, Reyes LF, Faverio P, Sotgiu G, Dore S, Rodriguez AH, Soni NJ, Restrepo MI; GLIMPinvestigators.Globalinitiativeformeticillin-resistantStaphylococcusaureuspneumonia(GLIMP):aninternational,observationalcohortstudy.LancetInfectDis.2016Sep1.[correspondingauthor]

55. Radovanovic D, Mantero M, Sferrazza Papa GF, Valenti V, Aliberti S, Di Marco F, SantusP.Formoterol fumarate + glycopyrrolate for the treatment of chronic obstructive pulmonarydisease.ExpertRevRespirMed.2016Sep1:1-11.

56. McDonnellMJ,Aliberti S,GoeminnePC,DimakouK, Zucchetti SC,Davidson J,WardC, Laffey JG,FinchS,PesciA,DupontLJ,FardonTC,SkrbicD,ObradovicD,CowmanS,LoebingerMR,RutherfordRM,DeSoyzaA,Chalmers JD.Multidimensionalseverityassessment inbronchiectasis:ananalysisofsevenEuropeancohorts.Thorax.2016Aug11.

57. CrivelliP,SverzellatiN,SotgiuG,AlibertiS. Is it feasibletoradiologicallymonitortheevolutionofnon-CFbronchiectasis?Respirology.2016Aug;21(6):1137.[correspondingauthor]

58. Chalmers JD, Reyes LF, Aliberti S, Restrepo MI. Empirical Coverage of Methicillin-ResistantStaphylococcusaureusinCommunity-AcquiredPneumonia:ThoseWhoDoNotRememberthePastAreDoomedtoRepeatIt.ClinInfectDis.2016Jul8.pii:ciw464.

59. Dara M, Solovic I, Sotgiu G, D'Ambrosio L, Centis R, Tran R, Goletti D, Duarte R, Aliberti S, deBenedictisFM,BothamleyG,SchabergT,Abubakar I,TeixeiraV,WardB,GratziouC,MiglioriGB.


TuberculosiscareamongrefugeesarrivinginEurope:aERS/WHOEuropeRegionsurveyofcurrentpractices.EurRespirJ.2016Aug4

60. WilsonR,AksamitT,AlibertiS,DeSoyzaA,ElbornJS,GoeminneP,HillAT,MenendezR,PolverinoE. Challenges in managing Pseudomonas aeruginosa in non-cystic fibrosis bronchiectasis. RespirMed.2016Aug;117:179-89

61. Aliberti S,TobaldiniE,GiulianiF,NunziataV,CasazzaG,SuigoG,D'AddaA,BonaitiG,RovedaA,Queiroz A, Monzani V, Pesci A, Blasi F, Montano N. Cardiovascular autonomic alterations inhospitalized patients with community-acquired pneumonia. Respir Res. 2016 Aug 4;17(1):98.[correspondingauthor]

62. Aliberti S, Masefield S, Polverino E, De Soyza A, Loebinger MR, Menendez R, Ringshausen FC,VendrellM,PowellP,ChalmersJD; onbehalfof theEMBARCStudyGroup.Researchpriorities inbronchiectasis: a consensus statement from the EMBARC Clinical Research Collaboration. EurRespirJ.2016Jun10.pii:ERJ-01888-2015.[correspondingauthor]

63. SotgiuG,Dore S, Chalmers JD, Aliberti S. Clinical phenotypes in bronchiectasis: right on track todevelopprecisionmedicineinrespiratorydiseases.IntJTubercLungDis.2016May;20(5):709.

64. AlibertiS,MorlacchiLC,FaverioP,Fernandez-BotranR,CosentiniR,ManteroM,PeyraniP,RamirezJ,BordonJ,BlasiF.Serumandexhaledbreathcondensate inflammatorycytokines incommunity-acquiredpneumonia:aprospectivecohortstudy.Pneumonia20168:8.[correspondingauthor]

65. AlibertiS,HillAT,ManteroM,BattagliaS,CentanniS,CiceroSL,LacedoniaD,SaettaM,ChalmersJD, Blasi F; SIP Bronchiectasis Audit Working Group. Quality standards for the management ofbronchiectasis in Italy: a national audit. Eur Respir J. 2016 Apr 13. pii: ERJ-00232-2016.[correspondingauthor]

66. SorianoJB,PatonJ,MartinBurriezaF,BillW,PannetierC,AlibertiS,AdcockIM,WagersS,MiglioriGB.TheERSResearchAgency:thebeginning.EurRespirJ.2016Apr;47(4):1017-23

67. DaraM,SolovicI,SotgiuG,D'AmbrosioL,CentisR,GolettiD,DuarteR,AlibertiS,deBenedictisFM,BothamleyG,SchabergT,AbubakarI,WardB,TeixeiraV,GratziouC,MiglioriGB.StatementoftheEuropean Respiratory Society and the European Region of the International Union AgainstTuberculosisandLungDisease:callforurgentactionstoensureaccesstoearlydiagnosisandcareoftuberculosisamongrefugees.EurRespirJ.2016Mar23.

68. Niculescu A, Noel J-L, Aliberti S, Rhode G. Introducing a new HERMES project on respiratoryinfections.Breathe2016;12:5–7

69. Sibila O, Rodrigo-Troyano A, Shindo Y, Aliberti S, RestrepoMI.Multidrug-resistant pathogens inpatientswithpneumonia coming from the community. CurrOpinPulmMed. 2016Mar4. [Epubaheadofprint][correspondingauthor]

70. Di Pasquale M, Aliberti S, Mantero M, Bianchini S, Blasi F. Non-Intensive Care Unit AcquiredPneumonia:ANewClinicalEntity?IntJMolSci.2016Feb25;17(3).

71. Aliberti S, Lonni S, Dore S,McDonnellMJ, Goeminne PC, Dimakou K, Fardon TC, Rutherford R,Pesci A, Restrepo MI, Sotgiu G, Chalmers JD. Clinical phenotypes in adult patients withbronchiectasis.EurRespirJ.2016Apr;47(4):1113-22[correspondingauthor]

72. Chalmers JD, McDonnell MJ, Rutherford R, Davidson J, Finch S, Crichton M, Dupont L, Hill AT,FardonTC,DeSoyzaA,AlibertiS,GoeminneP.Thegeneralizabilityofbronchiectasis randomizedcontrolledtrials:Amulticentrecohortstudy,RespiratoryMedicine2016

73. ChalmersJD,AlibertiS,PolverinoE,VendrellM,CrichtonM,LoebingerM,DimakouK,CliftonI,vander Eerden M, Rohde G, Murris-Espin M, Masefield S, Gerada E, Shteinberg M, Ringshausen F,HaworthC,BoersmaW,Rademacher J,Hill AT,Aksamit T,O’DonnellA,Morgan L,MilenkovicB,TrammaL,NevesJ,MenendezR,PaggiaroP,BotnaruV,SkrgatS,WilsonR,GoeminneP,DeSoyzaA,WelteT,TorresA,ElbornJS,BlasiF.TheEMBARCEuropeanBronchiectasisRegistry:protocolforaninternationalobservationalstudy.ERJOpenRes2015;1:00081-2015

74. Lonni S,Chalmers JD,GoeminnePC,McDonnellMJ,DimakouK,DeSoyzaA,PolverinoE,VandeKerkhoveC,RutherfordR,DavisonJ,RosalesE,PesciA,RestrepoMI,TorresA,AlibertiS.EtiologyofNon-CysticFibrosisBronchiectasisinAdultsandItsCorrelationtoDiseaseSeverity.AnnAmThoracSoc.2015Dec;12(12):1764-70.[correspondingauthor]


75. Bordon JM, Fernandez-Botran R, Wiemken TL, Peyrani P, Uriarte SM, Arnold FW, Rodriquez-HernandezL,RaneMJ,KelleyRR,BinfordLE,UppatlaS,CavallazziR,BlasiF,AlibertiS,RestrepoMI,FazeliS,MathurA,RahmaniM,AyesuK,RamirezJ.Bacteremicpneumococcalpneumonia:clinicaloutcomesandpreliminaryresultsofinflammatoryresponse.Infection.2015Dec;43(6):729-38.

76. AlibertiS,RamirezJ,CosentiniR,ValentiV,VozaA,RossiP,StolzD,LegnaniD,PesciA,RicheldiL,Peyrani P,Massari FM,Blasi F.Acutemyocardial infarction versusother cardiovascular events incommunity-acquiredpneumonia.ERJOpenRes2015;1:00020-2015[correspondingauthor]

77. Finch S, McDonnell MJ, Abo-Leyah H, Aliberti S, Chalmers JD. A Comprehensive Analysis of theImpact of Pseudomonas aeruginosa Colonisation on Prognosis in Adult Bronchiectasis. Ann AmThoracSoc.2015Nov;12(11):1602-11.1.

78. Uranga A, RestrepoMI, Chalmers JD, Blasi F, Aliberti S. Drug-resistant pathogens in community-acquired pneumonia. Community acquired infections 2015, vol. 2, p. 123-130, ISSN: 2225-6482,doi:10.4103/2225-6482.172654[Correspondingauthor]

79. Mirsaeidi M, Farnia P, Sadikot R, Hsueh PR, Aliberti S. Nontuberculous Mycobacteria:Epidemiologic,Mycobacteriologic,andClinicalAspects.BiomedResInt.2015;2015:523697.

80. HsuCH,ReyesLF,OrihuelaCJ,BuitragoR,AnzuetoA,SoniNJ,LevineS,J,HinojosaCA,AlibertiS,SibilaO,RodriguezA,ChalmersJD,Martin-LoechesI,BordonJ,BlanquerJ,SanzF,MarcosPJ,RelloJ, Solé-Violán J, Restrepo MI. Chromogranin A levels and mortality in patients with severesepsis.Biomarkers.2015May;20(3):171-6.

81. CarugatiM,FranzettiF,WiemkenT,KellyR,PeyraniP,BlasiF,RamirezJ,AlibertiS.De-escalationtherapyamongbacteraemicpatientswith community-acquiredpneumonia.ClinMicrobiol Infect.2015Jun23.[correspondingauthor]

82. BonaitiG,PesciA,MarruchellaA,LapadulaG,GoriA,AlibertiS.NontuberculousMycobacteria inNoncysticFibrosisBronchiectasis.BiomedResInt.2015;2015:197950.[correspondingauthor]

83. D'AmbrosioL,TadoliniM,CentisR,DuarteR,SotgiuG,AlibertiS,DaraM,MiglioriGB.Supportingclinicalmanagementofthedifficult-to-treatTBcases:theERS-WHOTBConsilium.IntJ InfectDis.2015Mar;32:156-60

84. Chalmers JD, Loebinger M, Aliberti S. Challenges in the development of new therapies forbronchiectasis.ExpertOpinPharmacother.2015Apr;16(6):833-50.

85. Chalmers JD, Aliberti S, Blasi F. Management of bronchiectasis in adults. Eur Respir J. 2015May;45(5):1446-62.

86. Lönnroth K, Migliori GB, Abubakar I, D'Ambrosio L, de Vries G, Diel R, Douglas P, Falzon D,GaudreauMA,GolettiD,GonzálezOchoaER,LoBueP,MatteelliA,NjooH,SolovicI,StoryA,TayebT,vanderWerfMJ,WeilD,ZellwegerJP,AbdelAzizM,AlLawatiMR,AlibertiS,ArrazoladeOñateW,BarreiraD,BhatiaV,BlasiF,BloomA,BruchfeldJ,CastelliF,CentisR,ChemtobD,CirilloDM,Colorado A, Dadu A, Dahle UR, De Paoli L, Dias HM, Duarte R, Fattorini L, GagaM, Getahun H,GlaziouP,GoguadzeL,DelGranadoM,HaasW,JärvinenA,KwonGY,MoscaD,NahidP,NishikioriN,Noguer I,O'Donnell J, Pace-AsciakA, PompaMG,PopescuGG,RobaloCordeiroC,RønningK,RuhwaldM,SculierJP,SimunovićA,Smith-PalmerA,SotgiuG,SulisG,Torres-DuqueCA,UmekiK,Uplekar M, van Weezenbeek C, Vasankari T, Vitillo RJ, Voniatis C, Wanlin M, Raviglione MC.Towards tuberculosis elimination: an action framework for low-incidence countries. Eur Respir J.2015Apr;45(4):928-52.

87. Blasi F, Aliberti S, Bonanni P, Mantero M, Odone A, Signorelli C. Pneumococcal vaccination inadults:recommendationsfromtheItalianSocietyofRespiratoryMedicine(SIMeR)andtheItalianSociety of Hygiene, Preventive Medicine and Public Health (SItI). Epidemiol Prev. 2014 Nov-Dec;38(6Suppl2):147-51.

88. Aliberti S, Giuliani F, Ramirez J, Blasi F; DURATION StudyGroup. How to choose the duration ofantibiotic therapy in patients with pneumonia. Curr Opin Infect Dis. 2015 Apr;28(2):177-84.[correspondingauthor]

89. Aliberti S, Bellelli G, Belotti M,Morandi A, Messinesi G, Annoni G, Pesci A. Delirium symptomsduring hospitalization predict long-termmortality in patientswith severe pneumonia. Aging ClinExpRes.2015Jan4[correspondingauthor]


90. Aliberti S, Messinesi G, Gamberini S, Maggiolini S, Visca D, Galavotti V, Giuliani F, Cosentini R,BrambillaAM,BlasiF,ScalaR,CaroneM,LuisiF,HarariS,VozaA,EsquinasA,PesciA.Non-invasivemechanicalventilationinpatientswithdiffuseinterstitiallungdiseases.BMCPulmMed.2014Dec5;14:194.[correspondingauthor]

91. Blasi F, Aliberti S, Signorelli C, Bonanni P. Raccomandazioni SIMeR-SITI : vaccinazioneantipneumococcica.MedicinaToracica2014;vol.34,p.3-7.

92. Blasi F.Chalmers JD,Aliberti S.COPDandBronchiectasis:phenotype,endotypeorCo-morbidity?COPD:Journalofchronicobstructivepulmonarydisease2014;11:603-604

93. Faverio P, Aliberti S, Ezekiel C, Messinesi G, Brenna A, Pesci A. Influenza A/H1N1 SeverePneumonia: Novel Morphocytological Findings in Bronchoalveolar Lavage. Interdiscip PerspectInfectDis.2014;2014:470825.

94. NovelliL,AlibertiS,PesciA.Dyspneaincracklinglungs.EurJInternMed.2014Dec;25(10):e115-695. BlasiF,CesanaG,ContiS,ChiodiniV,AlibertiS,FornariC,MantovaniLG.Theclinicalandeconomic

impact of exacerbations of chronic obstructive pulmonary disease: a cohort of hospitalizedpatients.PLoSOne.2014Jun27;9(6):e101228

96. MirsaeidiM,EbrahimiG,AllenMB,AlibertiS.PneumococcalVaccineandPatientswithPulmonaryDiseases.AmJMed.2014;127(9):886

97. Chalmers JD,AlibertiS.Preventingarterialcatheter-associatedbloodstream infections:commonsenseandchlorhexidine.CritCareMed.2014Jun;42(6):1533-4.

98. Brambilla AM, Aliberti S, Prina E, Nicoli F, Forno MD, Nava S, Ferrari G, Corradi F, Pelosi P,BignaminiA,TarsiaP,CosentiniR.HelmetCPAPvs.oxygentherapyinseverehypoxemicrespiratoryfailureduetopneumonia.IntensiveCareMed.2014;40(7):942-949

99. BellelliG,BruniA,MalerbaM,MazzoneA,AlibertiS,PesciA,AnnoniG.Geriatricmultidimensionalassessmentforelderlypatientswithacuterespiratorydiseases.EurJInternMed.2014;25(4):304-11

100. Aliberti S, Ramirez JA. Cardiac diseases complicating community-acquired pneumonia. CurrOpinInfectDis.2014;27(3):295-301

101. BellelliG,AlibertiS.Isittimefora"pneumo-geriatrician"forfrailoldpatientswithrespiratorydiseases?EurJInternMed.2014;25(4):303[correspondingauthor]

102. Mirsaeidi M, Farshidpour M, Ebrahimi G, Aliberti S, Falkinham JO 3rd. Management ofnontuberculousmycobacterialinfectionintheelderly.EurJInternMed.2014;25(4):356-63.

103. Wiemken TL, Carrico RM, Klein SL, Jonsson CB, Peyrani P, Kelley RR, Aliberti S, Blasi F,Fernandez-Gonzalez R, Lopardo G, Ramirez JA; CAPO Investigators. The effectiveness of thepolysaccharidepneumococcalvaccine for thepreventionofhospitalizationsduetoStreptococcuspneumoniae community-acquired pneumonia in the elderly differs between the sexes: Resultsfrom the Community-Acquired Pneumonia Organization (CAPO) international cohort study.Vaccine.2014Apr17;32(19):2198-203

104. AlibertiS,BrambillaAM,ChalmersJD,CillonizC,RamirezJ,BignaminiA,PrinaE,PolverinoE,Tarsia P, Pesci A, Torres A, Blasi F, Cosentini R. Phenotyping community-acquired pneumoniaaccording to the presence of acute respiratory failure and severe sepsis. Respir Res. 2014 Mar4;15:27.

105. Fernandez-Botran R, Uriarte SM, Arnold FW, Rodriguez-Hernandez L, Rane MJ, Peyrani P,WiemkenT,KelleyR,UppatlaS,CavallazziR,BlasiF,MorlacchiL,AlibertiS,JonssonC,RamirezJA,Bordon J. Contrasting Inflammatory Responses in Severe and Non-severe Community-acquiredPneumonia.Inflammation.2014;37(4):1158-66

106. Aliberti S,ManteroM,MirsaeidiM,Blasi F. Roleof vaccination inpreventingpneumococcaldiseaseinadults.ClinMicrobiolInfect.2014;20Suppl5:52-8[correspondingauthor]

107. Faverio P, Aliberti S, Bellelli G, Suigo G, Lonni S, Pesci A, RestrepoMI. Themanagement ofcommunity-acquiredpneumoniaintheelderly.EurJInternMed.2014;25(4):312-9[correspondingauthor]


108. ChalmersJD,GoeminneP,AlibertiS,McDonnellMJ,LonniS,DavidsonJ,PoppelwellL,SalihW, Pesci A, Dupont LJ, Fardon TC, De Soyza A, Hill AT.The Bronchiectasis Severity Index: AnInternationalDerivationandValidationStudy.AmJRespirCritCareMed.2014;189(5):576-85

109. SotgiuG,AlibertiS,GolettiD,MiglioriGB.TBelimination:adreamorarality?KeylessonfromtheERSexternalcourseinDubrovnik,Croatia.Breathe2013;9(6):459-461[correspondingauthor]

110. RestrepoMI,AlibertiS.Health-careassociatedpneumonia:Wheredowegonext?ClinInfectDis2014;58(3):340-1

111. Aliberti S, Kaye KS. The changing microbiology epidemiology of community-acquiredpneumonia.PostgradMed2013;125(6):31-42[correspondingauthor]

112. BonaitiG,AlibertiS,SuigoS,BelloniF,GiulianiF,PesciA.Quandoospedalizzareunpazienteconpolmoniteacquisitaincomunità.RassegnadiPatologiadell’ApparatoRespiratorio2013;28(4):189-195

113. CavallazziR,WiemkenT,ChristensenD,PeyraniP,BlasiF,LevyG,AlibertiS,KelleyR,RamirezJ; the CAPO Investigators. Predicting Mycobacterium tuberculosis in patients with community-acquiredpneumonia.EurRespirJ.2014;43(1):178-84

114. AlibertiS,CillonizC,ChalmersJD,ZanaboniAM,CosentiniR,TarsiaP,PesciA,BlasiF,TorresA. Multidrug-resistant pathogens in hospitalized patients coming from the community withpneumonia:aEuropeanperspective.Thorax2013;68(11):997-9[correspondingauthor]

115. CillónizC,PolverinoE,EwigS,AlibertiS,GabarrúsA,MenéndezR,MensaJ,BlasiF,TorresA.Impact of Age and Comorbidity on Etiology and Outcome in Community-Acquired Pneumonia.Chest.2013;144(3):999-1007

116. ReissigA,MempelC,SchumacherU,CopettiR,GrossF,AlibertiS.MicrobiologicalDiagnosisand Antibiotic Therapy in Patients with Community-Acquired Pneumonia and Acute COPDExacerbationinDailyClinicalPractice:ComparisontoCurrentGuidelines.Lung.2013;191(3):239-46

117. BordonJ,AlibertiS,DuvvuriP,WiemkenT,PeyraniP,NatividadI,Caceres-LaraA,DelapenhaR,BlasiF,RamirezJ.Earlyadministrationofthefirstantimicrobialsshouldbeconsideredamarkerofoptimalcareofpatientswithcommunity-acquiredpneumoniaratherthanapredictorofoutcomes.IntJInfectDis.2013;17(5):e293-8

118. Aliberti S, Faverio P, Blasi F. Hospital Admission Decision for Patients with Community-AcquiredPneumonia.CurrInfectDisRep.2013;15(2):167-76[correspondingauthor]

119. BilucagliaL,AlibertiS,ViganòEF,PantostiA,MonacoM,CiervoA,ManciniF,FaverioP,PesciA.A61-year-oldfemalewithchroniccoughandpurulentsputum.EurRespirJ.2013Feb;41(2):472-474[correspondingauthor]

120. Aliberti S, Messinesi G, Gramegna A, Tremolizzo L, Susani E, Pesci A. Diaphragmultrasonography in the management of patients with amyotrophic lateral sclerosis. AmyotrophLateralSclerFrontotemporalDegener.2013Mar;14(2):154-6[correspondingauthor]

121. Carugati M, Aliberti S, Franzetti F. Should health care systems and health care providersimplement a new pathway for hospitalized patientswith community-acquired pneumonia? ArchInternMed2012;172:1771

122. Aliberti S, Zanaboni AM,Wiemken T, Nahas A, Uppatla S, Morlacchi LC, Peyrani P, Blasi F,Ramirez J. Criteria for clinical stability in hospitalised patients with community-acquiredpneumonia.EurRespirJ.2013;42(3):742-9[correspondingauthor]

123. Bordon J, Aliberti S, Fernandez-Botran R, Uriarte SM, Rane MJ, Duvvuri P, Peyrani P,MorlacchiLC,BlasiF,RamirezJA.Understandingtherolesofcytokinesandneutrophilactivityandneutrophilapoptosisintheprotectiveversusdeleteriousinflammatoryresponseinpneumonia.IntJInfectDis.2013;17(2):e76-83[correspondingauthor]

124. Blasi F, Aliberti S, Mantero M, Centanni S. Compliance with anti-H1N1 vaccine amonghealthcareworkersandgeneralpopulation.ClinMicrobiolInfect.2012;18Suppl5:37-41

125. ArnoldFW,WiemkenTL,PeyraniP,MirsaeidiM,RamirezJA;CommunityAcquiredPneumoniaOrganization (CAPO) Study Group. Outcomes in females hospitalised with community-acquiredpneumoniaareworsethaninmales.EurRespirJ.2013May;41(5):1135-40


126. Blasi F, Bocchino M, Di Marco F, Richeldi L, Aliberti S. The role of biomarkers in lowrespiratorytractinfectionsEurJInternMed.2012;23(5):429-435

127. AlibertiS,BlasiF.Themanagementofpatientswithcommunity-acquiredpneumoniabeyondantibiotictherapyEurJInternMed.2012;23(5):389-390[correspondingauthor]

128. AlibertiS,BlasiF.ClinicalStabilityversusClinicalFailureinPatientswithCommunity-AcquiredPneumonia.SeminRespirCritCareMed.2012Jun;33(3):284-91[correspondingauthor]

129. ReißigA,CopettiR,MathisG,MempelC,SchulerA,ZechnerP,AlibertiS,NeumannR,KroegelC,HoyerH.Lungultrasoundinthediagnosisandfollow-upofcommunity-acquiredpneumonia.Aprospectivemulticentrediagnosticaccuracystudy.Chest.2012;142(4):965-72

130. AlibertiS,ZanaboniAM,BlasiF.Pneumonia in thecommunitycausedbymultidrug-resistantorganisms: keep working on probabilistic scores. Clin Infect Dis. 2012 May;54(10):1519-20[correspondingauthor]

131. ReissigA,GramegnaA,AlibertiS.Theroleoflungultrasoundinthediagnosisandfollow-upofcommunity-acquired.EurJInternMed.2012;23(5):391-397

132. BlasiF,ManteroM,AlibertiS.AntibioticsasimmunomodulantagentsinCOPDCurrentOpinioninPharmacology2012,12:1-7

133. Aliberti S, Di Pasquale M, Zanaboni AM, Cosentini R, Brambilla AM, Seghezzi S, Tarsia P,Mantero M, Blasi F. Stratifying Risk Factors for Multidrug-Resistant Pathogens in HospitalizedPatients Coming From the Community With Pneumonia. Clin Infect Dis. 2012; 54(4): 470-8[correspondingauthor]

134. Aliberti S,BrambillaAM,CosentiniR.Noninvasiveventilationor continuouspositiveairwaypressure in pulmonary edema patients with respiratory acidosis? Look at the bicarbonates.IntensiveCareMed.2011;37(12):2050-2051[correspondingauthor]

135. AlibertiS,RamirezJ,CosentiniR,BrambillaAM,ZanaboniAM,RossettiV,TarsiaP,PeyraniP,PifferF,BlasiF.LowCURB-65isoflimitedvalueindecidingdischargeofpatientswithcommunity-acquiredpneumonia.RespirMed.2011;105(11):1732-8[correspondingauthor]

136. AlibertiS,KellettJ.Wherearetheacutelyillbestcaredforandwhoshouldlookafterthem?EurJInternMed.2011Aug;22(4):323[correspondingauthor]

137. AlibertiS,AndrisaniMC,TarsiaP,TrevisanR,CosentiniR,LonghiL,PappaletteraM,NosottiM,Blasi F. Non-invasive continuous positive airway pressure inmonolateral lung transplant patientwithpneumoniaandIPF.MonaldiArchChestDis.2010Dec;73(4):169-75[correspondingauthor]

138. RiquelmeR,JiménezP,VidelaAJ,LopezH,ChalmersJ,SinganayagamA,RiquelmeM,PeyraniP, Wiemken T, Arbo G, Benchetrit G, Rioseco ML, Ayesu K, Klotchko A, Marzoratti L, Raya M,FigueroaS,SaavedraF,PrylukaD,InzunzaC,TorresA,AlvareP,FernandezP,BarrosM,GomezY,ContrerasC,Rello J, Bordon J, FeldmanC,Arnold F,NakamatsuR,Riquelme J,Blasi F,Aliberti S,CosentiniR,LopardoG,GnoniM,WelteT,SaadM,GuardiolaJ,RamirezJ.Predictingmortality inhospitalized patients with 2009 H1N1 influenza pneumonia. Int J Tuberc Lung Dis. 2011Apr;15(4):542-6

139. AlibertiS,PeyraniP,FilardoG,MirsaeidiM,AmirA,BlasiF,RamirezJA.Associationbetweentime to clinical stability and outcomes after discharge in hospitalized patients with community-acquiredpneumonia.Chest2011Aug;140(2):482-8[correspondingauthor]

140. AlibertiS,PifferF,BrambillaAM,BignaminiAA,RostiVD,MaraffiT,MonzaniV,CosentiniR.Acidemiadoesnotaffectoutcomesofpatientswithacutecardiogenicpulmonaryedematreatedwithcontinuouspositiveairwaypressure.CritCare.2010Nov1;14(6):R196[correspondingauthor]

141. MaraffiT,RuvoloL,AlibertiS,PifferF,CosentiniR.Earlyapplicationofnon-invasivecontinuouspositive airway pressure in acute respiratory distress syndrome due to a drug overdose: a casereport.InternEmergMed.2011Jun;6(3):275-6

142. Cosentini R, Brambilla AM, Aliberti S, Bignamini A, Nava S,Maffei A,Martinotti R, Tarsia P,MonzaniV,PelosiP.HelmetCPAPversusoxygen therapy to improveoxygenation incommunity-acquiredpneumonia:arandomizedcontrolledtrial.Chest2010Jul;138(1):114-20


143. BlasiF,BonardiD,AlibertiS,TarsiaP,ConfalonieriM,AmirO,CaroneM,DiMarcoF,CentanniS,GuffantiE.LongtermazithromycinuseinpatientswithChronicObstructivePulmonaryDiseaseandTracheostomy.PulmPharmacolTher.2010Jun;23(3):200-7

144. BlasiF,AlibertiS.LariacutizzazionedellaBPCO.Pneumologie2010;vol.1,p.37-45145. AlibertiS,BlasiF,ZanaboniAM,PeyraniP,TarsiaP,GaitoS,RamirezJA.Durationofantibiotic

therapyinhospitalizedpatientswithcommunity-acquiredpneumonia.EurRespirJ2010Jul;36(1):128-34[correspondingauthor]

146. Aliberti S, Blasi F,Morlacchi LC, Khirani S. Come scrivere un articolo scientifico. Rassegna dipatologiadell’apparatorespiratorio2010;vol.25,p.10-14.[correspondingauthor]

147. AlibertiS,BrockGN,PeyraniP,BlasiF,RamirezJA.ThepneumoniaseverityindexandtheCRB-65incancerpatientswithcommunity-acquiredpneumonia.IntJTubercLungDis2009Dec;13(12):1550-6

148. MirsaeidiM,PeyraniP,AlibertiS,FilardoG,BordonJ,BlasiF,RamirezJA.Thrombocytopeniaand Thrombocytosis at Time of Hospitalization Predict Mortality in Patients with Community-AcquiredPneumonia.Chest2010feb;137(2):416-20

149. PappaletteraM,AlibertiS,CastellottiP,RuvoloL,GiuntaV,BlasiF.Bronchiectasis:anupdate.ClinRespirJ.2009:3(3):126-34

150. MaestroniA,AlibertiS,AmirO,MilaniG,BrambillaAM,PifferF,TardiniF,CosentiniR.Acuteeffectsofpositiveend-expiratorypressureon left ventriclediastolic function inhealthy subjects.InternEmergMed.2009;4:249-254

151. CosentiniR,FolliC,CazzanigaM,AlibertiS,PifferF,GrazioliL,MilaniG,PappaletteraM,ArioliM,TardiniF,BrambillaAM.UsefulnessofsimplifiedacutephysiologyscoreIIinpredictingmortalityinpatientsadmittedtoanemergencymedicineward.InternEmergMed.20094;241-247

152. BlasiF,TarsiaP,AlibertiS.Chlamydophilapneumoniae.ClinMicrobiolInfect2009;15:29–35153. AlibertiS,MyersJA,PeyraniP,BlasiF,MenendezR,RossiP,CosentiniR,LopardoG,deVediaL,

Ramirez JA. The role of neutropenia on outcomes of cancer patients with community-acquiredpneumonia.EurRespirJ2009;33:142–147

154. Cosentini R, Aliberti S, Bignamini A, Piffer F, Brambilla AM. Mortality in acute cardiogenicpulmonaryedematreatedwithcontinuouspositiveairwaypressure.IntensiveCareMed.2008Feb;35(2):299-305

155. BossoneE,TrimarchiS,EspositoG,AlibertiS,CitroR,AllegraL,BlasiF.Chlamydiapneumoniaeandacuteaorticsyndrome:acallforamulti-institutionalstudy.MonaldiArchChestDis.2008Jun;70(2):68-70

156. Castellotti P, Rossetti V, Aliberti S, Peyrani P, Ruvolo L, Betti V, Pappalettera M, Tarsia P,RamirezJA,BlasiF.DiscrepanzetrailPneumoniaseveritàindexeilCRB-65nelsuggerireilricoveroper i pazienti affetti da polmonite acquisita in comunità: risultati del CAPO database. MedicinaToracica2008;vol.3,p.5-11,ISSN:0393-8506

157. Aliberti S, Amir A, Peyrani P,MirsaeidiM, AllenM,Moffett BK,Myers J, Shaib F, CirinoM,Bordon J, Blasi F, Ramirez JA. Incidence, etiology, timing and risk factors for clinical failure inhospitalizedpatientswithcommunity-acquiredpneumonia.Chest.2008Nov;134(5):955-62

158. Aliberti S. Impact of neutrophil functiononoutcomesof community-acquiredpneumonia inpatienytswithcancer.EurRespirRev2008;17:108,83-85[correspondingauthor]

159. Ramirez J,Aliberti S,MirsaeidiM,PeyraniP, FilardoG,AmirA,MoffettB,Gordon J,Blasi F,Bordon J. Acute Myocardial Infarction in Hospitalized Patients with Community-AcquiredPneumonia.ClinicalInfectiousDiseases2008;47(2):182-7

160. Tarsia P, Aliberti S, Blasi F. Antimicrobial Therapy in Community-Acquired Pneumonia.EuropeanInfectiousDisease2008;2(1):102-106

161. Cosentini R, Tarsia P, Canetta C, Graziadei G, Brambilla AM, Aliberti S, Pappalettera M,Tantardini F, Blasi F. Severe asthma exacerbation: role of acute Chlamydophila pneumoniae andMycoplasmapneumoniaeinfection.RespirRes2008,9:48


162. BlasiF,AlibertiS,AllegraL,PiattiG,TarsiaP,OssewadeJM,VerweijV,NijkampFP,FolkertsGChlamydophilapneumoniae inducesasustainedairwayhyperresponsivenessand inflammation inmiceRespirRes2007,8:83

163. Blasi F,Aliberti S, TarsiaP, SantusP,Centanni S,Allegra L. Prulifolxacin: abrief reviewon itspotential in treatment of acute exacerbartion of chronic bronchitis. Int J ChronObstruct PulmonDis.2007;2(1):27-31

164. BlasiF,AlibertiS,TarsiaPCliniclapplicationsofazithromycinmicrospheresinrespiratorytractinfections.IntJNanomedicine.2007;2(4):551-9

165. Blasi F, Aliberti S, Pappalettera M, Tarsia P 100 years of respiratory medicine: PneumoniaRespiratoryMedicine2007101,875-881

166. TarsiaP,AlibertiS,PappaletteraM,BlasiF.MixedCommunity-acquiredlowerrespiratorytractinfectionCurrentInfectiousDiseaseReports2007,9:14–20

167. Blasi F, Aliberti S, Baldessari C. Treatment in exacerbations of the upper and lower airways.MultidisciplinaryRespiratoryMedicine2007;vol.2,p.38-41.

168. BlasiF,TarsiaP,PappaletteraM,SaporitiM,AlibertiS.Antibiotic therapyandprophylaxis inCOPDRespiratoryMedicine:COPDUpdate(2007)2,124–132

169. Aliberti S, FalleniM, Tarsia P, VagoG, Zerbi P, BarberisM, Valenti V, Blasi F. A 13-year-oldfemalewithshortnessofbreathandpleuriticchestpain.EurRespirJ200628:876-882

170. Blasi F, Cazzola M, Tarsia P, Aliberti S, Baldessari C, Valenti V. Telithromycin in lowerrespiratorytractinfections.Futuremicrobiol2006;1(1),7-16

171. Blasi F, Aliberti S. Pneumonia: how important are local epidemiology and smoking habits?MonaldiArchChestDis.2006Mar;65(1):3-4

172. Blasi F, Tarsia P, Aliberti S, Santus P, Allegra L. Highlights on the appropriate use offluoroquinolonesinrespiratorytractinfections.PulmPharmacolTher.19(2006)11–19

173. Tarsia P, Aliberti S, Cosentini R, Blasi F Hospital-acquired pneumonia. Breathe, June 2005,Volume1,No4

174. Blasi F, Tarsia P, Aliberti S, Cosentini R, Allegra L. Chlamydia pneumoniae andMycoplasmapneumoniae.SeminRespirCritCareMed.2005Dec;26(6):617-624

175. BlasiF,CazzolaM,TarsiaP,CosentiniR,AlibertiS,SantusP,AllegraLAzithromycinandlowerrespiratorytractinfectionsExpertOpin.Pharmacother.(2005)6(13):2335-2351

176. Blasi F, Tarsia P, Aliberti S. Strategic targets of essential host-pathogen interactions.Respiration.2005Jan-Feb;72(1):9-25

B8b.Libri/Capitoliditesto/Multimediali/Traduzioni/Monografie

Libri2006 CosentiniR,AlibertiS.“L’ABCdellaventilazionemeccanicanon-invasiva(NIV)inurgenza”,Mc-GrawHillCompanies,2006,1stEdition2010 CosentiniR,AlibertiS,BrambillaAM.“L’ABCdellaventilazionemeccanicanon-invasiva(NIV)inurgenza”,Mc-GrawHillCompanies,2010,2ndEdition2011 BlasiF,AlibertiS,TarsiaP“Percorsidiagnosticiinpneumologia”,Ed:PercorsiEditorialidiCaroccieditore,Roma,20112014 BlasiF,AlibertiS,ManteroM.Polmonite.Scorediagnosticiepraticaclinica.Ed:PercorsiEditorialidiCarroccieditore,Roma,20142018 Chalmers JD,PolverinoE,Aliberti S.Bronchiectasis–TheEMBARCManual,DOI:10.1007/978-3-319-61452-6.Publisher:SpringerInternationalPublishing


Multimediali2014 CosentiniR,BrambillaAM,PifferF,AlibertiS.iABCHowtouseNIVintheacutesetting (applicazioneperiPhone-Apple)

Capitoliditesto

1. Blasi F, Aliberti S, Mantero M. Chapter 9. Impact of exacerbations in the natural course of COPDEuropeanRespiratorySocietyMonograph2013;60(TheSpectrumofBronchialInfection):84-95

2. Blasi F, Aliberti S. “Malattia polmonare cronica ostruttiva” inMedicina Critica Tomo II, a cura di EzioRomano,UTETscienzemediche,2010,pag837-847

3. Blasi F, Tarsia P, Cosentini R, Aliberti S. “Acute exacerbation of COPD: application of evidence-basedguidelines” 111 – 122, in Cazzola M, Sethi S, Blasi F, Anzueto A. “Therapeutic strategies in acuteexacerbationsinCOPD”,ClinicalpublishingOxford,2009

4. BlasiF,AlibertiS,BenemeiS,GeppettiP.Reazioniavversepolmonari-In:Reazioniavverseafarmaci;[acuradi]A.P.Caputi,F.DePonti,L.Pagliaro.-Milano:RaffaelloCortina,2009.-ISBN978-88-6030-278-6.-p.237-250

5. AlibertiS,TarsiaP,BlasiF“Majorkeytopicsconcerningshortcourseantimicrobialtherapyincommunity-acquired pneumonia. Evidence efficacy” in “2008 Yearbook of Respiratory care clinics and appliedtechnologies”byAntonioEsquinas

6. Aliberti S, Blasi F. “Infezioni respiratorie” in Allegra L, Blasi F, Canonica GW, Centanni S, Girbino G“Malattierespiratorie:l’essenziale”ElsevierMasson,2008

7. Cosentini R, Aliberti S. “L’ABC della ventilazione meccanica non invasiva in urgenza”, McGraw-Hill,October2006

8. Cosentini R, Aliberti S, Brambilla AM. “L’ABC della ventilazionemeccanica non invasiva in urgenza. IIEdizione”,McGraw-Hill,October2010

9. BlasiF,CosentiniR,TarsiaP,AlibertiS,BrambillaAM,FolliC,“Infezionirespiratorienontubercolari”inLarizza,“Trattatodimedicinainterna”,Piccin,2008

10. TarsiaP,AlibertiS,PappaletteraM,ZanardelliM,BlasiF..”Putativeroleofantimicrobialactivityinthe treatment of asthma” pag. 123-140, in “Polosa. R, Volgate ST Therapeutic Strategies ASTHMACurrenttreatments”ClinicalPublishingAtlasMedicalPublishingLtd,2007

11. Blasi F, Aliberti S. “Polmoniti da ipersensibilità” (pag. 1199-1204); “Bronchiectasie” (1224-1226);“Pleuriti” (1259-1264) in Massimo Vanoli “Sintomi, Diagnosi, Terapia in medicina interna” SelectaMedica,2007

Traduzioni1. Francis C. “Respiratory care”, Blackwell, 2006 (Traduttore e curatore della traduzione italiana per

commissionediMcGrawHillItalia)2. Traduttore per la versione italiana dell’“American Journal of Respiratory and Critical CareMedicine”,

2006Monografie2018 (Editor)ERSMonograph.“Bronchiectasis”EditedbyJamesDChalmers,Eva

PolverinoandStefanoAlibertiDOI:10.1183/2312508X.erm81182017 (Editor)ERSMonograph.“Anti-infectivesandthelung”EditedbyStefanoAliberti,

JamesD.ChalmersandMathiasW.Pletz.DOI:10.1183/2312508X.erm7517ISBN(electronic):978-1-84984-084-2


2017 DiPasqualeM,AlibertiS,tarsiaP,BlasiF.IdentifyingpatientswithpneumoniaduetoMDRorganismscomingfromthecommunity.ERSMonograph.“Anti-infectivesandthelung”DOI:10.1183/2312508X.erm7517ISBN(electronic):978-1-84984-084-2

2014 SotgiuG,BrownJ,LipmanM,PianaA,MatteelliA,CentisR,AlibertiS,MiglioriGN. Tuberculosis.ERSMonogr2014;66:112-1272014 Chalmers JD, Pletz MW, Aliberti S. Introduction on the European respiratory.

Monographoncommunityacquiredpneumonia 2014 AlibertiS,FaverioP.EarlyoutcomesinCAP:clinicalstability,clinicalfailureand nonresolvingpneumonia.EuropeanRespiratoryMonograph“Community-acquired pneumonia”63,pp205-2182013 Blasi F, Aliberti S, Mantero M. Impact of exacerbation in the natural course of

COPD.EuropeanrespiratoryMonograph“ThespectrumofbronchialInfection”pp84-95

Abstract

Autoredipiùdi180abstractaccettatiepresentaticomeposteropresentazionioraliacongressinazionaliedinternazionalidal2003adoggi

C. ATTIVITA’DIDATTICA

C1.DOCENZAINMASTERUNIVERSITARI

Anno Titolodelladocenza Master

2011 DirettoreeDocentedelCorsodiEcografiaToracica

MasterIIlivelloinTerapiaIntensivaUniversitàdegliStudidiMilano

2014-adoggi EmogasanalisieNIV Master di I livello in Fisioterapia eRiabilitazioneRespiratoriaUniversitàdegliStudidiMilano

2012-2013 NIMVapplicataallospecificopatologico Master di I livello in Fisioterapia eRiabilitazioneRespiratoriaUniversitàdegliStudidiMilano

2011-2012

Meccanismifisiologici,valutazioneeausiliperlacompensazionedellaPEEPintrinsecanelBPCO

Master di I livello in Fisioterapia eRiabilitazioneRespiratoriaUniversitàdegliStudidiMilano

2011-2012

NIMV:indicazioniecontroindicazioni Master di I livello in Fisioterapia eRiabilitazioneRespiratoriaUniversitàdegliStudidiMilano


Anno Titolodelladocenza Master

2010-2011

EmogasanalisieInsufficienzarespiratoria


2009-2010 NIMVnelBPCOriacutizzatoNIMVnell’edemapolmonareacuto

CorsodiperfezionamentoinVentilazioneMeccanicaNonInvasivaNIMV

2009-2010

EmogasanalisieInsufficienzarespiratoria


2008-2009 EmogasanalisiApplicazioniclinichedellaventilazionemeccanicanelpazienteacutoecronico


2007-2008 EmogasanalisiecasicliniciApplicazioniclinichedellaventilazionemeccanicanelpazienteacutoecronicoModalitàdiventilazione(Assistentealladocenza)


2012 Assistenzadomiciliare:ossigenoterapiadomiciliare

MasterdiIlivelloinCurePalliativeUniversitàdegliStudidiMilanoBicocca

2012 Gestionedelladispneaedellafaseterminaledellamalattiarespiratoria


2011 Malattieneuromuscolari MasterdiIlivelloinCurePalliativeUniversitàdegliStudidiMilanoBicocca

2011 Trattamentodell’insufficienzarespiratorianellafaseavanzata


C2.RESPONSABILITA’EDOCENZADICORSIELETTIVIUNIVERSITARI

Responsabile e/o docente dei seguenti Corsi Elettivi della Facoltà diMedicina e Chirurgia dell’UniversitàdegliStudidiMilanoBicocca:


AnnodiCorso CorsoElettivo CFU Ore Ruolo

2017-2018 Bronchiettasie Responsabileedocente

2014-2015 EcografiadeltoraceH4101D127

2 10 Responsabileedocente

2014-2015 SmetterediFumareH4101D223

1 18 Responsabile



2013-2014 SmetterediFumareH4101D223

1 18 Responsabile

2012-2013 EcografiadeltoraceI0201D027


2012-2013 SmetterdiFumareH4101D223

1 12 Responsabile

2012-2013 LepneumopatieinfiltrativediffuseH4101D090

2 21 Docente

2012-2013 La ventilazione polmonare noninvasivaH4101D089

2 18 Docente



2011-2012 La ventilazione polmonare noninvasivaH4101D089

2 18 Docente

C3.DOCENZAINCORSIUNIVERSITARI,FACOLTA’DIMEDICINAECHIRURGIA

• Coordinatore del Corso System Diseases 2, International Medical School, Università degli studi diMilano(dal2018)

Nell’ultimo anno accademico 2017/2018 per l’Università degli Studi diMilano (SSD DocenteMED/10)hasvolto80oretotaliattribuite,cosìsuddivise:

• 12 ore di lezione per l’International Medical School - System Diseases 2-, 3° anno dicorso(CFU:4)

• 12oredi lezione+6oredididatticanonformaleperMedicinaeChirurgiadellaLineaPolo Centrale (Classe LM-41) per Semeiotica e Patologia degli apparati I, 3° anno di corso (SSD:MED/10;CFU:4)


• 50 di attività professionalizzanti per Medicina e Chirurgia della Linea Polo Centrale(ClasseLM-41)perSemeioticaePatologiadegliapparatiI,3°annodicorso(SSD:MED/10;CFU:1)

AnnoAccademico

Corso Ruolo Note

UniversitàdegliStudidiMilano

2017-20182016-20172009-20102008-20092007-2008

CorsodiSemeioticaePatologiadegliApparatiI,Malattiedell’App.Respiratorio

Docente -Almenounalezione/annoeservizioditutoraggiostudenti

2017-20182016-20172009-20102008-2009

ScuoladiSpecializzazioneinMalattiedell’ApparatoRespiratorio

Docente -Almenounalezione/annoeservizioditutoraggiostudenti

UniversitàdegliStudidiMilanoBicocca

2014-20152013-20142012-20132011-20122010-2011

CorsodiLaureainInfermieristicaAssistenzaInfermieristicainMedicinaSpecialistica,Malattiedell’ApparatoRespiratorio

Docente -Lezioniperil60-70%delleoretotaliassegnateaMalattiedell’App.Respiratoriodurantetuttii5anniaccademici-Esaminatore(provascritta)finecorsodurantetuttii5anniaccademici

2014-20152013-20142012-20132011-2012

CorsodiSemeioticaeSistematicaI,Malattiedell’App.Respiratorio

Docente -Lezioniperil50-65%delleoretotaliassegnateaMalattiedell’App.Respiratoriodurantetuttii4anniaccademici-Servizioditutoraggiostudenti-Esaminatore(provascrittaedorale)finecorsodurantetuttii4anniaccademici

2013-20142012-20132011-20122010-2011

ScuoladiSpecializzazioneinMalattiedell’ApparatoRespiratorio

Docente

-Almenounalezioneclinicaodiricerca/annodurantetuttii4anniaccademici-Esaminatore(provaorale)pertuttigliannidispecializzazione

C4.MEMBER/SPONSOROFDOCTORALTHESIS

• Membro internazionale nel Board per PhD “Exploration of challenging phenotypes in COPD:Aspergillus fumigatus, bronchiectasis and asthma-COPD overlap”; promotore: Prof.W Janssens;Co-promotori: Prof B Vanaudenaerde e Prof L Dupont; PhD: Stephanie Everaerts; 25 Settembre2018,Leuven,Belgio


C5. TESI DI LAUREA STUDENTI FACOLTA’ MEDICINA E CHIRURGIA e SPECIALIZZANDI IN MALATTIEDELL’APPARATORESPIRATORIO

Anno Studente/Specializzan

do

Titolodellatesi Valutazione

Ruolo

UniversitàdegliStudidiMilano

2017/2018 NicolòVanoni

Primaanalisidelregistroitalianodellemicobatteriosipolmonarinon-tubercolari(TesidiSpecializzazione)

70/70eLode

Relatore

2016/2017 ElisaFranceschi

Bronchiettasiecomemalattiagenetica:risultatodiunoscreeninggeneticoallargato

110/110eLode

Correlatore

2016/2017 AndreaGramegna

Theroleofairwayglucoseinadultpatientswithcysticfibrosis(TesidiSpecializzazione)

70/70elode

Correlatore

2015/2016 CattaneoBenedetta

Ruolodellariabilitazionerespiratorianeipazientiadultiaffettidabronchiettasie(TesidiSpecializzazione)

70/70 Correlatore

2012-2013

FabioGiuliani

Individualizzazionedelladuratadellaterapiaantibioticainpazienticonpolmoniteacquisitaincomunità:unostudiorandomizzato,controllato

110/110 Correlatore

2011-2012

VanessaNunziata

AlterazionidelcontrolloNervosocardiovascolareinpazienticoncommunity-acquiredpneumonia

110/110elode

Correlatore

2010-2011

AndreaGramegna

Ilruolodell’ecografiadeldiaframmanellavalutazionepneumologicadelladistrofiamiotonicadiSteinert

110/110elode

Correlatore

2009-2010

LetiziaCorinnaMorlacchi

Infiammazioneeprognosinellapolmoniteacquisitaincomunità:studioprospetticoosservazionale

110/110elode

Correlatore

2008-2009

MartaFrancescaDiPasquale

Valutazionedell’incidenza,fattoridirischioemortalitàdellepolmonitiassociateallecuremediche(HCAP):studioprospetticoosservazionale

110/110elode

Correlatore

2008-2009

PietroBianchi

Inquinamentoatmosfericoeaccessialprontosoccorso:studioprospetticoosservazionale

106/110 Correlatore

2008-2009 Giulia Ilfallimentocliniconellapolmonite 110/110 Correlatore



do


Ruolo

Salomoni ospedalizzata:studioprospetticoosservazionale

2008-2009

ElenaMagni

Leriacutizzazionidellabroncopneumopatiacronicaostruttiva:ruolodeimarcatoribiochimici

110/110elode

Correlatore

2007-2008

ValeriaRossetti

Studioprospetticoosservazionalesullaassociazionetrapolmonitiacquisiteincomunitàedeventicardiovascolari

110/110elode

Correlatore

2007-2008

SabrinaDella

Patrona

Studioprospettico,osservazionalesuHCAPricoveratepressoIRCCSFondazionePOMARE(tesidispecializzazione)

70/70elode

Correlatore

UniversitàdegliStudidiMilanoBicocca

2015-2016 EdoardoSimonetta

Ruolodeivirusnelleriacutizzazionidibronchiettasie

110/110 Correlatore

2014-2015 StefanoCarlo

Zucchetti

Ruolodeivirusinpazientiadultiaffettidabronchiettasie.Studioprospetticoosservazionale.

110/110elode

Correlatore

2013-2014 ValentinaPaolini

IndividualizzazionedeltrattamentoconCPAPscafandronell’insufficienzarespiratoriaacutadapolmonite(TesidiSpecializzazione)

70/70elode

Correlatore

2012-2013

SaraLonni

Fattoripredittividioutcomenegativoinpazienticonbronchiettasie:unostudioprospetticodicoorte

110/110 Correlatore

2012-2013

MauroBelotti

FattoriprognosticineltrattamentoconCPAPscafandrodellapolmoniteospedalizzata

104/110 Correlatore

2011-2012

FrancescoMulè

L’ecografiadeldiaframmanellavalutazionerespiratoriadelpazienteaffettodaSclerosiLateraleAmiotrofica

95/110 Correlatore



do


Ruolo

2010-2011

GiuliaBonaiti

Lostressossidativopolmonareindottodainquinamentoambientaleinsoggettiesposti:studioprospetticoosservazionale

110/110elode

Correlatore

C6.MEMBROCONSIGLISCUOLEDISPECIALIZZAZIONE

2016-adoggi Membro del Consiglio di Scuola di Specializzazione in Malattie dell’ApparatoRespiratorio,UniversitàdegliStudidiMilano

2011-2016 Membro del Consiglio di Scuola di Specializzazione in Malattie dell’ApparatoRespiratorio,UniversitàdegliStudidiMilanoBicocca

2011-2016 Membro del Consiglio di Scuola di Specializzazione in Malattie dell’ApparatoCardiovascolare,UniversitàdegliStudidiMilanoBicocca

2011-2016 Membro del Consiglio di Scuola di Specializzazione in Medicina d’Emergenza-Urgenza,UniversitàdegliStudidiMilanoBicocca

2011-2016 Membro del Consiglio di Scuola di Specializzazione in Nefrologia, Università degliStudidiMilanoBicocca.

C7.INVITICOMERELATOREACONGRESSIINTERNAZIONALI

• Invitato come Speaker per 65 relazioni in congressi internazionali dal 2011 ad oggi soprattutto inambitodi infezionidell’apparatorespiratorio(includepolmoniti),bronchiettasie,micobatterinontubercolari,fibrosicistica,vaccinazioni,riacutizzazionidiBPCO

Dataeluogo Titolodellarelazione Congresso

13Giugno2018,WashingtonDC,USA

Phenotypinginbronchiectasis 3rdWorldBronchiectasisConference

18Maggio2018,SanPietroburgo,Russia

Cysticfibrosisbronchiectasisversusnon-cysticfibrosisbronchiectasis

IXAnnualNorthwesternScientificandPracticalConferenceonCYSTICFIBROSISwithInternationalParticipation“PracticeofCysticFibrosisTreatment:Microbiology,Pulmonology,EndocrinologyIssues”

25Maggio2018,Parma,Italia

Bronchiectasis RESPIRATIONDAY



9Giugno2018,Londra,UK

Managementofnon-responsivepneumonia

EURODIME2018,2ndEuropeanRespiratoryDiseasemeeting

10Settembre2018,Parigi,Francia

Assessingtheeducationalneeds(individual,multi-disciplinaryteam,country,profession/specialty)

EuropeanRespiratorySocietyInternationalCongres2018

10Settembre2018,Parigi,Francia

Diagnosingbronchiectasisandcysticfibrosis

EuropeanRespiratorySocietyInternationalCongres2018

20-23Giugno2018,LisbonaPortogallo

Pulmonarynontuberculousmycobacterialdiseases

SummerSchoolofAdultRespiratoryMedicine

20-23Giugno2018,LisbonaPortogallo

Bronchiectasis SummerSchoolofAdultRespiratoryMedicine

9Giugno2018,Belgrado,Serbia

TheimplementationofbestpracticeproceduresaroundEurope

41stEuropeanCysticFibrosisConference

18Gennaio2018,Berlino,Germania

Bronchiectasis:Imaging,pulmonaryfunctiontesting,LCIandwhatelse?

5thInternationalWorkshoponLungHealth

8Luglio2017,Milano,Italia

DefinitionofBronchiectasis 2ndWorldBronchiectasisConference

18Febbraio2017,Vicenza,Italia

PatógenosMultiresistentesenNeumoníaAdquiridaenlaComunidad.

ZRespJornadasenrespiratorio2017

22Maggio2017,WDC,USA

PneumoniainImmunocompromisingMetabolicConditions

AmericanThoracicSocietyConference2017

20Maggio2017,WDC,USA

Non-TuberculousMycobacteriaPulmonaryDiseaseATS/ERSProjectCommittee:RespiratoryHealthinMigrantandRefugeePopulations

AmericanThoracicSocietyConference2017

24-25Maggio2017,WDC,USA

Howtoimplementresearchinpneumoniaintheimmunocompromisedhost

2ndAnnualInternationalRespiratoryInfectionsConference“Clinical&TranslationalResearchinPneumonia:DefiningaResearchAgendaforTodayandTomorrow”

19-21Gennaio2017,Budapest

ManagementofNCFBEpatientscolonizedwithPseudomonasaeruginosa

4thInternationalWorkshoponLungHealth

1Marzo2017,Vienna,Austria

Makingthecorrectdiagnosisofnon-cysticfibrosisbronchiectasisandtheroleofimaging

EuropeanSocietyofRadiologyAnnualCongress2017

7Giugno2017,Basilea,CH

Treatingnon-CFbronchiectasis CHESTCongress2017



9Settembre,2017,Milano,Italia

MultidrugresistantbacteriainCommunity-acquiredpneumonia

EuropeanRespiratorySocietyInternationalCongress2017


Diagnosisandtreatmentchallengesinbronchiectasis



BronchiectasisasfriendofNTM–andviceversa



CeremonyfortheERSResearchAward:InnovationinNon-TuberculousMycobacteriaScienceandMedicine


6Maggio2017,Londra,UK

PneumoniaorExacerbationofCOPD? EUropeanREspiratoryDIseaseMEetingNewTrendsinManagementofLungDiseases

16Marzo2017,Dubai

PneumococcalandInfluenzavaccinationinAdults

GulfThoracicCongress2017

17Marzo2017,Dubai

SteroidsforCommunity-acquiredPneumonia


17Marzo2017,Dubai

TheroleofNTMinBronchiectasisPatients GulfThoracicCongress2017

8Luglio2017,Milano

ReportoftheEMBARC/BRRBronchiectasisdefinitionworkinggroup

2ndWorldBronchiectasisConference2017

7Maggio2016,Porto,Portogallo

Opportunitiesinbronchiectasisresearch 7thPortugeseBronchiectasisStudyGroupMeeting

15-17Aprile2016,Shanghai,Cina

Definitionofpneumoniaandimplications CHESTWorldCongress2016


BronchiectasisTreatment CHESTWorldCongress2016


AntibioticselectioninCAP CHESTWorldCongress2016

9Marzo2016,Londra,UK

Allergicbronchopulmonaryaspergillosis NationalBronchiectasisStudyDay

2-6Marzo2016,Vienna,Austria

Classificationandimpactofbrnchiectasis EuropeanCogressofRadiology2016

2-5Marzo2016,Leipzig,Germania

TheEMBARCRoadmap 57DGPKongress

12-13Febbraio2016,Barcellona,

MRSAmanagement:theGLIMPstudy 21stInternationalSymposiumninfectionsinthecriticallyillpatient



Spagna

5-7Febbraio2016,Pune,India

CardiovasculardiseasesinpatientswithCOPD

2ndInternationalCOPDconference

15-17Gennaio2016,Monaco

PneumoniaorexacerbationofCOPD? 3rdInternationalworkshoponlunghealth

24-28Ottobre2015,Montreal,Canada

Pro-ShouldwechangethenameHCAPandgobacktoCAP?

ACCPCongressCHESTAnnualMeeting2015

17Ottobre2015,NoviSad,Serbia

MDRpathogensinpatientswithCAP 4thCongressofRespiratoryMedicine,Serbia2015

26-30Settembre2015,Amsterdam,Olanda

Non-CFbronchiectasis:Understandingtheheterogeneityofthedisease


26-30Settembre2015,Amsterdam,Olanda

ShouldwechangeourantibioticstrategyinAECOPDorCAP+COPDpatients?


7Maggio2015,Chisinau,Moldavia

MDR-pathogensincommunity-acquiredpneumonia

Emergingdrug-resistantpathogensinrespiratoryinfectiousdiseases,DAAD

7-11Marzo2015,Isfahan,Iran

Chronicinfectionwithnon-tuberculousmycobacteriainpatientswithnon-CFbronchiectasis:comparisonwithotherpathogens

1stAsianAfricanCongressofMycobacteriology

4-7Marzo2015,Dubai

Multidrug-resistantpathogensinpatientswithCAP


4-7Marzo2015,Dubai

Non-CFBronchiectasis:Arenewedinteresttopulmonologists


25-30Ottobre2014,Austin,TX,USA

Differentiatingcommonpathogensfromemergentpathogensinpatientswithacuterespiratoryinfections:MRSA

ACCPCongressCHESTAnnualMeeting2014

10-13Maggio2014,Barcellona,Spagna

TheEuropeanperspectiveofcommunity-acquiredpneumonia(CAP)andhealth-careassociatedpneumonia(HCAP)

24thECCMIDInternationalcongressoftheEuropeanSocietyofclinicalmicrobiologyandinfectiousdiseases

12-14Dicembre2013,Monaco

NIV:stateoftheart 1stInternationalworkshoponlunghealth.COPD:thenewparadigms

11Ottobre2013,Mendoza,Argentina

Ultrasonografiapulmonarenneumonia 41°CongresoArgentinodeMedicinaRespiratoria




Cardiovasculareventsinpenumonia 41°CongresoArgentinodeMedicinaRespiratoria


Evaluandolaestabilidadclinica,riesgosparamultiresistentesymanejoenterapiaintensiva

41°CongresoArgentinodeMedicinaRespiratoria


Duraciondeltratamientoantibioticoenneumonia

41°CongresoArgentinodeMedicinaRespiratoria


Casosclinicoseninfeccionespulmonares 41°CongresoArgentinodeMedicinaRespiratoria

22-24Marzo2013,Praga

Roleofvaccinesinpreventingpneumococcaldisease

2ndESCMIDConferenceontheImpactofVaccinesonPublicHealth

20Ottobre2015,Barcellona,Spagna

ERSFramework ENIRRIMeeting

17-20Giugno2015,Barcellona,Spagna

RespiratoryInfections EuropeanrespiratorySocietyAdultHERMESSummerSchool,

17-20Giugno2015,Barcellona,Spagna

TBandemergingpandemicpathogens EuropeanrespiratorySocietyAdultHERMESSummerSchool,

20-21Maggio2015,Denver,CO,USA

Multidrug-resistantpathogensinCAP CAPOResearchSymposiumClinical&translationalresearchinpneumonia,influenzaandemergingrespiratorypathogens:definingaresearchagendafortodayandtomorrow

23Gennaio2015,Barcellona,Spagna

UpdateontheEMBARCresearchroadmap EMBARCMeeting

7-10Luglio2014,Milan,Italy

HowtosolveMCQsfortheHermesExamination

HERMESNationalSummerSchool2014

6-9Maggio2013,Milano

HowtosolveMCQsfortheHermesExaminationPulmonaryVascularDiseases

HERMESNationalSummerSchool(ERS)

9-12Luglio2012,Milano

DiagnosticTest HERMESNationalSummerSchool(ERS)

12-15Dicembre2011,Milano

DiagnosticTest HERMESNationalSummerSchool(ERS)




Interstitiallungdiseases HERMESNationalSummerSchool(ERS)


Pulmonaryvasculardiseases HERMESNationalSummerSchool(ERS)

C8.INVITICOMERELATOREACONGRESSINAZIONALI

Invitatocomerelatorea>100congressi/corsisuterritorionazionaledal2005adoggi

D.ATTIVITA’CLINICO-ASSISTENZIALE

D1.RUOLIeSTRUTTURE

1.8.2016–adoggi DirigenteMedico

UOCBroncopneumologia,IRCCSFondazioneCàGranda,OspedaleMaggiorePoliclinico,Milano• Responsabile del Programma Bronchiettasie, del Programma DiscinesiaCiliarePrimitiva/Kartagener,edelProgrammaMalattiaPolmonaredaNTMdelPoliclinicodiMilano

1.8.2011–31.3.2016 DirigenteMedico ClinicaPneumologicaeSub-intensivaRespiratoria AOSanGerardo,Monza

• Responsabiledell’AmbulatorioBronchiettasie1.8.2009–30.11.2010DirigenteMedico

U.O. Broncopneumologia, IRCCS Fondazione Cà Granda, Ospedale MaggiorePoliclinico,Milano

10.9.2008–1.7.2009 DirigenteMedico U.O.Medicinad’UrgenzaedAccettazione,IstitutoClinicoHumanitas, Rozzano,Milano9.6.2008–9.9.2008 DirigenteMedico

U.O.BroncopneumologiaIRCCSFondazioneCàGrandaOspedaleMaggiorePoliclinico,Milano(vedisopra)

1.4.2008–31.5.2008 DirigenteMedico U.O.Medicinad’UrgenzaedAccettazione IstitutoClinicoHumanitas, Rozzano,Milano(vedisopra)


1.11.2007–31.5.2008MedicospecialistavolontarioU.O.BroncopneumologiaIRCCSFondazioneCàGrandaOspedaleMaggiorePoliclinico,Milano(vedisopra)

1.1.2008–31.5.2008Medicodiguardia Casadicuraprivata“Capitanio”

IstitutoAuxologico,Milano

D2.COMPETENZETECNICO-METODOLOGICHEACQUISITEEcografiadelTorace;Spirometria;Pletismografia;TestallaMetacolina;TestdiMantoux(PPD,Tubercolina);Emogasanalisiarteriosa;TestdelCammino;Saturimetrianotturna;Espettoratoindotto;Fibrobroncoscopia;Polisonnografia;Toracentesi;DrenaggiPleurici;GestioneCannulatracheostomica;VentilazioneMeccanicaNon-invasivaE.LINGUESTRANIEREInglese(Ottimaconoscenzascrittoeparlato)Level1FirstCertificate inEnglish(ESOL),CouncilofEuropeLevelB2,UniversityofCambridge,UK.March2004,MilanCertificateofstudies, intermediate level,LanguageCourse inEnglish,EducationalEnglishCulture,15 July1995,MaltaEnglish Language Course, University Collage of Wales, Aberystwyth, Lower intermediate, 21 July, 1991,Wales,UKFrancese(Buonaconoscenzascrittoeparlato)F.REFERENZE

Prof.FrancescoBlasi Dipartimento di Fisiopatologia Medico-ChirurgicaedeitrapiantiUniversitàdegliStudidiMilano,Milano

[email protected]

Dr.JulioRamirez ProfessorofMedicineChief,DivisionofInfectiousDiseasesDepartmentofMedicineUniversityofLouisville,Louisville,KY,USA

[email protected]

DrMarcosRestrepo AssociateProfessorofMedicineUniversity of Texas health Science Center,Medicine,SanAntonio,TX,USA

[email protected]


Prof.AntoniTorres CapdeSeccioUVIRServeidePneumologiaCatedraticdeMedicinaHospitalClinic,barcelona,Spain

[email protected]

DrMarkWElliott DepartmentofRespiratoryMedicineStJamesUniversityHospital,Leeds,UK

[email protected]

Ledichiarazioniresenelpresentecurriculumsonodaritenersirilasciateaisensidegliartt.46e47delDPRn.445/2000.Ilpresentecurriculum,noncontienedatisensibiliedatigiudiziaridicuiall’art.4,comma1,lettered)ede)delD.Lgs.30.6.2003n.196.Data 18.10.18 Luogo Milano

Firma

Aliberti Stefano Ottobre 2018 - unimi.it · Pneumologia (SIP/IRS) 2014-2018 Rappresentante dei...

Documents

Transcript of Aliberti Stefano Ottobre 2018 - unimi.it · Pneumologia (SIP/IRS) 2014-2018 Rappresentante dei...